All Stories

On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer.

Mar 10, 2025 - 15:42
 0
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer.
Read More

Tags:

Previous Article

In the midst of chaos, some good news emerges for domestic intermodal

Next Article

STAT+: Judge rules against compounding group; Hims’ shares fall

Related Posts

Walgreens: Bridging the gap between patient and medication

Walgreens: Bridging the gap between patient and medication

Feb 10, 2025  0

Pfizer's blockbuster ADC Adcetris nabs FDA approval to treat large B-cell lymphoma

Pfizer's blockbuster ADC Adcetris nabs FDA approval to ...

Feb 12, 2025  0

Regulatory tracker: Eisai's Alzheimer's drug Leqembi rejected in Australia

Regulatory tracker: Eisai's Alzheimer's drug Leqembi re...

Mar 3, 2025  0